Cargando…

Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain

There have been increases in prescriptions of high strength opioids for chronic non-cancer pain (CNCP), but CNCP patients perceive themselves as being at low risk of opioid overdose and generally have limited overdose awareness. This study examined how an overdose prevention intervention (opioid saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Schofield, Joe, Parkes, Tessa, Mercer, Fiona, Foster, Rebecca, Hnízdilová, Kristina, Matheson, Catriona, Steele, Wez, McAuley, Andrew, Raeburn, Fiona, Skea, Lucy, Baldacchino, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204494/
https://www.ncbi.nlm.nih.gov/pubmed/37218970
http://dx.doi.org/10.3390/pharmacy11030088
_version_ 1785045847262625792
author Schofield, Joe
Parkes, Tessa
Mercer, Fiona
Foster, Rebecca
Hnízdilová, Kristina
Matheson, Catriona
Steele, Wez
McAuley, Andrew
Raeburn, Fiona
Skea, Lucy
Baldacchino, Alexander
author_facet Schofield, Joe
Parkes, Tessa
Mercer, Fiona
Foster, Rebecca
Hnízdilová, Kristina
Matheson, Catriona
Steele, Wez
McAuley, Andrew
Raeburn, Fiona
Skea, Lucy
Baldacchino, Alexander
author_sort Schofield, Joe
collection PubMed
description There have been increases in prescriptions of high strength opioids for chronic non-cancer pain (CNCP), but CNCP patients perceive themselves as being at low risk of opioid overdose and generally have limited overdose awareness. This study examined how an overdose prevention intervention (opioid safety education, naloxone training, and take-home naloxone (THN)) delivered by community pharmacists for patients prescribed high-strength opioids for CNCP would work in practice in Scotland. Twelve patients received the intervention. CNCP patients and Community Pharmacists were interviewed about their experiences of the intervention and perceptions of its acceptability and feasibility. CNCP patients did not initially perceive themselves as being at risk of overdose but, through the intervention, developed insight into opioid-related risk and the value of naloxone. Pharmacists also identified patients’ low risk perceptions and low overdose awareness. While pharmacists had positive attitudes towards the intervention, they outlined challenges in delivering it under time and resource pressures and during the COVID-19 pandemic. Overdose prevention interventions are required in the CNCP population as this group has elevated risk factors for overdose but are commonly overlooked. Customised overdose prevention interventions for CNCP patients attend to gaps in overdose awareness and risk perceptions in this population.
format Online
Article
Text
id pubmed-10204494
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102044942023-05-24 Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain Schofield, Joe Parkes, Tessa Mercer, Fiona Foster, Rebecca Hnízdilová, Kristina Matheson, Catriona Steele, Wez McAuley, Andrew Raeburn, Fiona Skea, Lucy Baldacchino, Alexander Pharmacy (Basel) Article There have been increases in prescriptions of high strength opioids for chronic non-cancer pain (CNCP), but CNCP patients perceive themselves as being at low risk of opioid overdose and generally have limited overdose awareness. This study examined how an overdose prevention intervention (opioid safety education, naloxone training, and take-home naloxone (THN)) delivered by community pharmacists for patients prescribed high-strength opioids for CNCP would work in practice in Scotland. Twelve patients received the intervention. CNCP patients and Community Pharmacists were interviewed about their experiences of the intervention and perceptions of its acceptability and feasibility. CNCP patients did not initially perceive themselves as being at risk of overdose but, through the intervention, developed insight into opioid-related risk and the value of naloxone. Pharmacists also identified patients’ low risk perceptions and low overdose awareness. While pharmacists had positive attitudes towards the intervention, they outlined challenges in delivering it under time and resource pressures and during the COVID-19 pandemic. Overdose prevention interventions are required in the CNCP population as this group has elevated risk factors for overdose but are commonly overlooked. Customised overdose prevention interventions for CNCP patients attend to gaps in overdose awareness and risk perceptions in this population. MDPI 2023-05-22 /pmc/articles/PMC10204494/ /pubmed/37218970 http://dx.doi.org/10.3390/pharmacy11030088 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Schofield, Joe
Parkes, Tessa
Mercer, Fiona
Foster, Rebecca
Hnízdilová, Kristina
Matheson, Catriona
Steele, Wez
McAuley, Andrew
Raeburn, Fiona
Skea, Lucy
Baldacchino, Alexander
Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain
title Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain
title_full Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain
title_fullStr Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain
title_full_unstemmed Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain
title_short Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain
title_sort feasibility and acceptability of an overdose prevention intervention delivered by community pharmacists for patients prescribed opioids for chronic non-cancer pain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204494/
https://www.ncbi.nlm.nih.gov/pubmed/37218970
http://dx.doi.org/10.3390/pharmacy11030088
work_keys_str_mv AT schofieldjoe feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain
AT parkestessa feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain
AT mercerfiona feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain
AT fosterrebecca feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain
AT hnizdilovakristina feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain
AT mathesoncatriona feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain
AT steelewez feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain
AT mcauleyandrew feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain
AT raeburnfiona feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain
AT skealucy feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain
AT baldacchinoalexander feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain